#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Audrey Kues Email
Director Quality Assurance . CEL-SCI Corporation
How to contact Audrey Kues
Join and see Audrey's contact info for free!Phone
Current Roles
Employees:
18Revenue:
$7.5MAbout
CEL-SCI\'s story is one of vision, persistence, and survival in the face of overwhelming odds. Despite downturns in the biotech sector, lack of funding, and a lengthy clinical trial process associated with the development of its investigational therapy for advanced primary head and neck cancer, CEL-SCI is finally approaching the end game! Our lead investigational immunotherapy, Multikine® (Leukocyte Interleukin, Injection), has been tested in Phase I and II clinical trials, and is now enrolling patients for a global Phase III trial. Multikine (Leukocyte Interleukin, Injection) is the full name of this investigational therapy, which, for simplicity, is referred to in the remainder of this page as Multikine*.CEL-SCI Corporation Address
8229 Boone BoulevardWolf Trap, VA
United States